• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Cardiovascular testing after emergency department presentation may not reduce risk of myocardial infarction

byShayna BejaimalandAnees Daud
July 2, 2017
in Cardiology, Emergency, Imaging and Intervention, Public Health, Surgery
Reading Time: 3 mins read
Variability in out-of-hospital pediatric cardiac arrest outcomes
Share on FacebookShare on Twitter

1. Based on this retrospective cohort study, noninvasive testing done within 30 days of patient presentation with chest pain at the emergency department reduced the amount of coronary angiography and revascularization done at 1 year.

2. Noninvasive testing, however, did not reduce risk of acute myocardial infarction admission at one year.

Evidence Rating Level: 2 (Good)

Study Rundown: Appropriate investigation of emergency department (ED) patients with chest pain but with negative findings of ischemia is important in order to reduce rates of acute myocardial infarction (AMI) and decrease rates of unnecessary testing. This retrospective cohort study aimed to determine whether noninvasive cardiovascular imaging or coronary angiography was associated with changes in rates of coronary revascularization or AMI admission in patients who present to the ED with chest pain but no findings of ischemia.

Patients who received cardiovascular testing had increased cardiovascular risk at baseline and greater risk of AMI admission at 30 days than those who did not receive testing. Noninvasive testing within 30 days of presentation was associated with an increase in coronary angiography and revascularization at one year however, no decrease in AMI admissions. Strengths of this study included its large size and comparison of weekday and weekend rates to ensure there was no selection bias. Limitations of this study included potential inability to generalize to those who are uninsured or older than 65 years old. Also, acute myocardial infarction admission rates were used as a surrogate for mortality. It is possible that mortality rates would be decreased with earlier screening where AMI rates would not change.

Click to read the study, published in JAMA Internal Medicine

RELATED REPORTS

Duloxetine is effective in refractory chronic cough

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

Relevant Reading: Testing of Low-Risk Patients Presenting to the Emergency Department With Chest Pain: A Scientific Statement From the American Heart Association

In-Depth [retrospective cohort]: This large, retrospective cohort study was conducted from 2011 to 2012 using weekday and weekend national claims data from MarketScan Commercial Claims and Encounters. Data was divided into weekday and weekend information to account for differences in availability of cardiovascular testing. The study participants were privately insured adults aged 18 to 64 years that presented to the ED with chest pain without an initial diagnosis of acute myocardial ischemia. The exposures of interest were noninvasive testing or coronary angiography within 2 days or 30 days of ED presentation. Outcomes studied were coronary revascularization and admission for acute myocardial infarction at 7, 30, 180 and 365 days. Statistical analysis included multivariable logistic regression and adjusted for age, sex, hypertension, diabetes, dyslipidemia, ischemic heart disease, chronic kidney disease, cerebrovascular disease, peripheral vascular disease, tobacco use and presence of intervention in the preceding year.

A total of 926 633 privately insured patients were included in the cohort. As expected, those who presented on a weekday were more likely to receive cardiovascular testing than those who presented on a weekend. Of those who underwent testing, 91% had noninvasive testing. On adjusted analyses, patients who underwent cardiovascular testing within 2 or 30 days had higher rates of coronary angiography (36.5 per 1000 patients tested; 95%CI 21.0 to 52.0), revascularization (22.8 per 1000 patients tested; 95%CI 10.6 to 35.0) but no significant change in AMI admissions (7.8 per 1000 patients tested; 95%CI -1.4 to 17.0) at the end of follow-up of 365 days.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: chest painmyocardial infarction
Previous Post

The ONTT: Intravenous steroids lead to faster visual recovery in optic neuritis [Classics Series]

Next Post

E-cigarette use linked to increased risk of cigarette smoking in adolescents and young adults

RelatedReports

Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Chronic Disease

Duloxetine is effective in refractory chronic cough

January 21, 2026
Using HEART score to risk stratify patients with chest pain is safe but underutilized in the ED
Cardiology

The efficacy 3 months of dual antiplatelet therapy is similar to 12 months in patients with acute coronary syndrome

January 12, 2026
Lariat device for left atrial appendage exclusion associated with adverse events
Cardiology

Atrial fibrillation risk is high following coronary artery bypass grafting and is low but gradually accumulates following percutaneous coronary intervention

January 13, 2026
Nearly Half of All Pediatric Buprenorphine Exposures Result in Hospitalization
Cardiology

Clopidogrel monotherapy is superior to aspirin for secondary prevention in coronary artery disease

October 30, 2025
Next Post
Smoking during pregnancy associated with aerobic fitness of children

E-cigarette use linked to increased risk of cigarette smoking in adolescents and young adults

Tonsillectomy may have short-term benefits in recurrent throat infection

Low risk allergy symptoms not linked to true penicillin allergy

Treatment of subclinical hypothyroidism ineffective in older adults

Treatment of subclinical hypothyroidism ineffective in older adults

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Prognostic associations of anthropometric indices vary by clinical outcomes
  • Anitocabtagene autoleucel associated with sustained clinical response in heavily pretreated multiple myeloma
  • Gene therapy shows sustained benefit in Wiskott–Aldrich syndrome
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.